Gadsden presided over a massive period of growth for Merck & Company. A strong believer in the power of research and development, he increased spending in this area four fold during his tenure – from $32 million to $125 million. Under his leadership, Merck’s revenues and earnings quadrupled reaching $1 billion and $225 million, respectively.